224 related articles for article (PubMed ID: 3196886)
1. Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
Helin HJ; Isola JJ; Helle MJ; Adlercreutz H
Breast Cancer Res Treat; 1988 Sep; 12(1):67-73. PubMed ID: 3196886
[TBL] [Abstract][Full Text] [Related]
2. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.
Helin HJ; Helle MJ; Helin ML; Isola JJ
Am J Clin Pathol; 1988 Aug; 90(2):137-42. PubMed ID: 2456008
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
[TBL] [Abstract][Full Text] [Related]
5. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
Kiang DT; Kollander R
J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
[TBL] [Abstract][Full Text] [Related]
6. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
7. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
8. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors.
Brentani MM; Nagai MA
Cancer Detect Prev; 1983; 6(1-2):241-7. PubMed ID: 6883383
[TBL] [Abstract][Full Text] [Related]
11. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
13. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
14. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
Kommoss F; Pfisterer J; Idris T; Giese E; Sauerbrei W; Schäfer W; Thome M; Pfleiderer A
Anal Quant Cytol Histol; 1994 Jun; 16(3):203-10. PubMed ID: 7916848
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay.
Wilbur DC; Willis J; Mooney RA; Fallon MA; Moynes R; di Sant'Agnese PA
Mod Pathol; 1992 Jan; 5(1):79-84. PubMed ID: 1371874
[TBL] [Abstract][Full Text] [Related]
17. Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.
Lacombe MJ; Delarue JC; Mouriesse H; Contesso G; Friedman S; Sancho-Garnier H; Travagli JP; May-Levin F
Gynecol Oncol; 1989 Feb; 32(2):174-9. PubMed ID: 2910778
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.
Pertschuk LP; Kim DS; Nayer K; Feldman JG; Eisenberg KB; Carter AC; Rong ZT; Thelmo WL; Fleisher J; Greene GL
Cancer; 1990 Oct; 66(8):1663-70. PubMed ID: 2208020
[TBL] [Abstract][Full Text] [Related]
19. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.
Ruder AM; Lubin F; Wax Y; Geier A; Alfundary E; Chetrit A
Cancer; 1989 Jul; 64(1):196-202. PubMed ID: 2731116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
